Literature DB >> 19893831

Spider bites - Assessment and management.

George Braitberg1, Leslie Segal.   

Abstract

BACKGROUND: Spider bite is common, but most species cause minimal or no effects. Patients may be misinformed regarding the nature and consequences of a bite. Understanding the current literature can assist the physician in the management of spider bite patients.
OBJECTIVE: This article reviews the current literature on spider bites and describes the clinical assessment and management of the medically important spider bites. DISCUSSION: Most spider bite is minor and causes nothing more than local irritation. Some spiders can cause significant morbidity and rarely, mortality. Lay identification of the spider has not been shown to be reliable. Latrodectism (red back spider envenomation) is characterised by pain (local, radiating, and regional); systemic symptoms occur less commonly. Funnel web spider bite is a medical emergency; a pressure immobilisation bandage should be applied and the patient transferred to a hospital with available antivenom and resuscitation facilities. Clinicians must consider spider bite in the differential diagnosis of unexplained autonomic and neurological dysfunction, particularly in children. In Australia, skin ulceration is more likely to be an infective, inflammatory or traumatic cause than a case of necrotising arachnidism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19893831

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  8 in total

1.  A national survey examining recognition, demand for antivenom, and overall level of preparedness for redback spider bites in Japan.

Authors:  Toru Hifumi; Tomoya Okazaki; Arisa Manabe; Hideyuki Hamaya; Satoshi Egawa; Satoshi Fujimi; Akihiko Yamamoto; Yuichi Koido; Yuko Abe; Kenya Kawakita; Kazuo Umezawa; Yasuhiro Kuroda
Journal:  Acute Med Surg       Date:  2016-04-18

2.  Case Files of the Medical Toxicology Fellowship at the Oregon Poison Center: Thallotoxicosis.

Authors:  Matthew S Correia; Annette M Lopez
Journal:  J Med Toxicol       Date:  2022-03-10

3.  Clinical characteristics of redback spider bites.

Authors:  Toru Hifumi; Satoshi Fujimi; Takuya Yamagishi; Satoru Arai; Kyoko Sawabe; Akihiko Yamamoto; Manabu Ato; Keigo Shibayama; Akihiko Ginnaga; Nobuaki Kiriu; Hiroshi Kato; Yuichi Koido; Junichi Inoue; Masanobu Kishikawa; Yuko Abe; Kenya Kawakita; Masanobu Hagiike; Yasuhiro Kuroda
Journal:  J Intensive Care       Date:  2014-11-02

4.  Update of antivenom supply for redback spider bites in Japan.

Authors:  Toru Hifumi; Hisashi Taki; Akihiko Yamamoto; Manabu Ato; Yuichi Koido; Yasuhiro Kuroda
Journal:  J Intensive Care       Date:  2015-02-11

5.  An irritable infant and the runaway redback: an instructive case.

Authors:  Thomas R Ward; James A Falconer; John A Craven
Journal:  Case Rep Emerg Med       Date:  2011-09-28

Review 6.  Poisonous Spiders: Bites, Symptoms, and Treatment; an Educational Review.

Authors:  Farzad Rahmani; Seyed Mahdi Banan Khojasteh; Hanieh Ebrahimi Bakhtavar; Farnaz Rahmani; Kavous Shahsavari Nia; Gholamreza Faridaalaee
Journal:  Emerg (Tehran)       Date:  2014

7.  Low Health System Performance, Indigenous Status and Antivenom Underdosage Correlate with Spider Envenoming Severity in the Remote Brazilian Amazon.

Authors:  Vanderson Souza Sampaio; André Alexandre Gomes; Iran Mendonça Silva; Jacqueline Sachett; Luiz Carlos Lima Ferreira; Sâmella Oliveira; Meritxell Sabidò; Hipócrates Chalkidis; Maria Graças Vale Barbosa Guerra; Jorge Luis Salinas; Fan Hui Wen; Marcus Vinícius Guimarães Lacerda; Wuelton Marcelo Monteiro
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

8.  Freeze-dried equine-derived redback spider antivenom: a local irritation study by intramuscular injection in rabbits and a repeated-dose toxicity study in rats.

Authors:  Akihiko Yamamoto; Satomi Harano; Noriko Shinya; Ayataka Nagano; Yoshinobu Miyatsu; Kyouko Sawabe; Takayuki Matsumura; Manabu Ato; Motohide Takahashi; Hisashi Taki; Toru Hifumi
Journal:  J Toxicol Pathol       Date:  2018-02-19       Impact factor: 1.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.